Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
52 hedge funds and large institutions have $1.02B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
18% more funds holding
Funds holding: 44 → 52 (+8)
8% less capital invested
Capital invested by funds: $1.11B → $1.02B (-$93.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$115M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$28.3M |
| 3 |
P8IP
Pier 88 Investment Partners
San Francisco,
California
|
+$16.6M |
| 4 |
JP Morgan Chase
New York
|
+$14.5M |
| 5 |
Jane Street
New York
|
+$6.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$34.6M |
| 2 |
OA
Oxbow Advisors
Austin,
Texas
|
-$5.63M |
| 3 |
Morgan Stanley
New York
|
-$4.83M |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$3.88M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.17M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HDIM
51
Hanson & Doremus Investment Management
Burlington,
Vermont
| $14K | +$14.6K | +134 | New |
|
|
PA
52
Parallel Advisors
San Francisco,
California
| $1K | – | – | – |
|
|
53
Verition Fund Management
Greenwich,
Connecticut
| – | -$1.17M | -1,000,000 | Closed |
|
|
BCM
54
BlueCrest Capital Management
St Helier,
Jersey
| – | -$3.88M | -33,302 | Closed |
|
55
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$815K | -7,000 | Closed |
|
56
Rockefeller Capital Management
New York
| – | -$4K | -41 | Closed |
|
BSX.PRA Hedge Fund Activity: Q2 2022 in Review
52 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q2 2022, worth a combined $1.02B — down 8.4% from $1.11B a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BSX.PRA positions and 4 closed out — a net gain of 8 holders — while 18 added to existing stakes and 12 trimmed.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $115M. The largest seller was Allianz Asset Management, cutting an estimated $34.6M.
- 52 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q2 2022, up from 44 in Q1 2022.
- Funds reported $1.02B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q2 2022, down 8.4% quarter-over-quarter.
- 12 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q2 2022 and 4 closed out, a net change of +8 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q2 2022 was Russell Investments Group, an estimated $115M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q2 2022 was Allianz Asset Management, an estimated $34.6M sold.
Based on aggregated 13F filings for Q2 2022.